Ufp Technologies UFPT
NASDAQ UFPT
$277.34 -1.25 (-0.45%)
As of: Sep 10, 2026 · 3:59 PM EDT

Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026)

Ufp Technologies' (UFPT) quarterly Liabilities and Shareholders Equity came in at $681.9 million in Q2 2026, up 7.44% on a YoY basis from $634.7 million in Q2 2025, and up 1.07% quarter-over-quarter from $674.7 million in Q1 2026.

Analysis

Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Ufp Technologies (UFPT) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $681.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 7.44% year-over-year to $681.9 million; the trailing twelve-month figure through Jun 2026 stood at $2.7 billion (up 4.7% YoY), and the FY2025 full-year result was $655.1 million, up 4.15% from the prior year.
  • Liabilities and Shareholders Equity rose to $681.9 million in Q2 2026 per UFPT's latest filing, from $674.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $681.9 million in Q2 2026 and bottomed at $363.3 million in Q1 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $508.7 million across 5 years, with a median of $415.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity jumped 81.81% in 2022, then gained 0.74% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $378.2 million in 2022, then climbed by 6.86% to $404.1 million in 2023, then jumped by 55.64% to $629.0 million in 2024, then climbed by 4.15% to $655.1 million in 2025, then climbed by 4.1% to $681.9 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $681.9 million, $674.7 million, and $655.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 93.31 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 13.87 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 6.46 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 10.74 Bn
10 Ufp Technologies 2.15 Bn 2.14 Bn 50.92 Mn 681.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 681.91 Mn
Mar 31, 2026 674.68 Mn
Dec 31, 2025 655.08 Mn
Sep 30, 2025 652.82 Mn
Jun 30, 2025 634.66 Mn
Mar 31, 2025 642.64 Mn
Dec 31, 2024 629.00 Mn
Sep 30, 2024 638.51 Mn
Jun 30, 2024 422.40 Mn
Mar 31, 2024 407.68 Mn
Dec 31, 2023 404.14 Mn
Sep 30, 2023 399.81 Mn
Jun 30, 2023 397.99 Mn
Mar 31, 2023 390.78 Mn
Dec 31, 2022 378.19 Mn
Sep 30, 2022 388.32 Mn
Jun 30, 2022 395.05 Mn
Mar 31, 2022 363.35 Mn
Dec 31, 2021 334.13 Mn
Sep 30, 2021 220.69 Mn